欧洲与亚洲国家骨质疏松病例发现策略比较综述
本文比较了英国、德国、中国、日本和韩国在骨质疏松病例发现策略上的差异,综述了各国现行治疗指南并纳入专家意见。多数国家以髋部或椎体影像学骨折定义骨质疏松,无骨折时则采用风险因素评估联合双能X线吸收法测定的面积骨密度等不同组合。文章指出区域间策略存在差异,尤其对无骨折患者,需更统一的病例发现方法。
要点
- 多数国家以髋部或椎体影像学骨折定义骨质疏松病例。
- 无骨折时,T值≤-2.5被接受用于识别骨质疏松,但并非所有国家仅用DXA。
- 亚洲多数国家仅在特定年龄阈值以上提供aBMD扫描,但指南推荐有风险因素的年轻患者也应评估骨折风险。
核心结论
- 骨质疏松病例发现策略存在区域差异,尤其在无骨折患者中,需要更统一的病例发现方法以改善骨折前识别。
研究设计与样本
- 综述比较了英国、德国(含奥地利和德语区瑞士)、中国、日本和韩国的现行骨质疏松病例发现策略,纳入各国现行治疗指南和关键意见领袖的专家意见。
主要发现
- 多数国家以髋部或椎体影像学骨折定义骨质疏松,其他类型骨折或无骨折时采用风险因素评估联合双能X线吸收法测定的面积骨密度等不同组合。
- 无骨折时T值≤-2.5被接受用于识别骨质疏松,但并非所有国家接受DXA作为唯一标准,且各国对aBMD之外还需临床风险因素的要求不同。
- 亚洲多数国家仅在特定年龄阈值以上提供aBMD扫描,但所有指南推荐有风险因素的年轻患者应进行骨折风险评估。
关键数值与推荐
- 无骨折时,T值≤-2.5被接受用于识别骨质疏松。
- 亚洲多数国家仅在特定年龄阈值以上提供aBMD扫描。
- 所有指南推荐有风险因素的年轻患者应进行骨折风险评估。
临床怎么用
- 临床医生应依据当地指南,结合骨折史、风险因素评估和aBMD测量来发现骨质疏松病例,尤其对无骨折患者注意各国策略差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While many clinical guidelines recommend screening for osteoporosis for early detection and treatment, there is great diversity in the case-finding strategies globally. We sought to compare case-finding strategies, focusing on the approaches used in European and Asian countries. This article provides an overview of the current case-finding strategies in the UK, Germany (including Austria and German-speaking regions of Switzerland), China, Japan, and Korea. We conducted a review of current treatment guidelines in each country and included expert opinions from key opinion leaders. Most countries define osteoporosis among patients with a radiographically identified fracture of the hip or the vertebrae. However, for other types of fractures, or in the absence of a fracture, varying combinations of risk-factor assessment and areal bone mineral density (aBMD) assessed by dual X-ray absorptiometry are used to define osteoporosis cases. A T-score ≤ - 2.5 is accepted to identify osteoporosis in the absence of a fracture; however, not all countries accept DXA alone as the sole criteria. Additionally, the critera for requiring clinical risk factors in addition to aBMD differ across countries. In most Asian countries, aBMD scanning is only provided beyond a particular age threshold. However, all guidelines recommend fracture risk assessment in younger ages if risk factors are present. Our review identified that strategies for case-finding differ regionally, particularly among patients without a fracture. More homogenized ways of identifying osteoporosis cases are needed, in both the Eastern and the Western countries, to improve osteoporosis case-finding before a fracture occurs.Case-finding in osteoporosis is essential to initiate treatment and minimize fracture risk. We identified differences in case-finding strategies between Eastern and Western countries. In the absence of a diagnosed fracture, varying combinations of risk factors and bone density measurements are used. Standardized case-finding strategies may help improve treatment rates.
引用
- Burden AM, Tanaka Y, Xu L, et al. Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review. Osteoporos Int. 2020. PMID: 33305343. doi:10.1007/s00198-020-05756-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。